Chamber and committees

ScotRail and Caledonian Sleeper submit their forward forecasts as part of annual budget processes. Forward forecasts of ScotRail and Caledonian Sleeper revenue and the level of subsidy required are subject to ongoing discussions between the train operating companies, Transport Scotland and Scottish Rail Holdings.

Work on the five-year review of Parts 1 to 3 of the Civil Litigation (Expenses and Group Proceedings) (Scotland) Act 2018 is in progress and the Scottish Government will publish the review as soon as possible.

The NHS Scotland Support and Intervention Framework is one of the key elements of the evidence-based approach to monitoring performance and managing risk across the NHS in Scotland.

All NHS Boards have recently been reviewed against the framework for finance purposes.

Following this review the decision was made for NHS Grampian to be escalated to Stage Three of the Framework for finance. This is based on the deterioration of the Board’s financial position during 2024-25.

Stage Three escalation comes into effect from January 2025 and involves enhanced monitoring and support including increased oversight and coordinated engagement from Scottish Government. This will include monitoring by and meetings with the Scottish Government’s Finance Delivery Unit, as well as further engagement with the NHS Scotland Director of Health and Social Care Finance.

The Scottish Government will continue to work with NHS Grampian to monitor their financial position and assist with longer term financial planning and improvement.

A breakdown of successful and unsuccessful applications for the last four financial years has been provided in the following table as requested:

Registers of Scotland is accountable to the Scottish Parliament and its performance is regularly scrutinised by the Economy and Fair Work Committee. The Scottish Government also receives regular reports on the progress RoS is making in delivery of its Corporate Plan 2022-2027 strategic objectives, which includes updates on the achievement against RoS’s Key Performance Indicators for its service performance (timeliness, quality and customer satisfaction).

The supply of medicines is currently a reserved matter for the UK Government. We continue to engage with the UK Government’s Department of Health and Social Care on all medicines supply issues. The NHS in Scotland has robust processes in place to manage supply issues when they do arise and normally there are alternative products which can be prescribed and dispensed. 

The Scottish Government is aware that, since April 2024, there has been ongoing supply issues with the availability of naloxegol (Moventig®) tablets. Initially both strengths (12.5mg and 25mg) were impacted by this supply issue. The latest information provided by the Department of Health and Social Care indicates that supplies of naloxegol (Moventig®) 25mg strength are back in stock however supply issues remain for the 12.5mg strength and that this supply issue is expected to continue until May 2025. The Scottish Government issued advice to NHS Scotland in April 2024 on this supply issue and available alternatives. 

The alcohol marketing review is being carried out as part of the remit of work Public Health Scotland (PHS) is already commissioned and funded to do. PHS is a national Special Health Board, funded by the Scottish Government to work collaboratively, focusing on increasing healthy life expectancy and reducing premature mortality.

The Scottish Government meets with the Scottish Ambulance Service regularly to discuss demand, capacity, and pressures. Since escalating to REAP level four the Service has been submitting twice daily situational reports on pressures and we have been meeting with their operations Director on a frequent basis.

The First Minister has also Chaired several meetings to discuss NHS pressures more widely which were attended by SAS and other key partners.

The Scottish Ambulance Service has implemented a number of actions to mitigate the effects of pressures throughout the healthcare system over the past few weeks and continues to maintain its focus on improving response times to patients.

I wrote to the UK Minister for Energy Consumers on 17 October 2024. Scottish Ministers proposed changes to the ECO4 scheme to enable ECO financed work to benefit from stronger management and quality control as part of local and national fuel poverty schemes in Scotland. Scottish Ministers emphasised the need to re-build public trust in the reliability of `government backed’ schemes, citing the inappropriate use of spray foam insulation in lofts as an example.

The UK Minister for Energy Consumers replied on 19 December to say that the UK Government was reviewing the current consumer protections in place for retrofit work and how they could be strengthened. They advised that any changes in their approach to consumer protection will form part of the UK Government’s Warm Homes Plan.

We will continue to press the UK Government to allow a better managed approach to ECO4 delivery in Scotland and request further details about any proposed changes to consumer protections.

The Resuscitation Research Group’s PADmap web portal is expected to go live by Spring 2025. PADmap will provide organisations and communities with more evidence on the optimal location to place their defibrillators in order to increase their potential impact.